GlaxoSmithKline PLC ADR

Yahoo Finance • 2 days ago

Nvidia Who? This Highflyer Keeps Popping Onto This Elite Screen

While Nvidia once again fails to make the list, the best mutual funds keep scooping up shares this one stock. Continue Reading... Full story

Yahoo Finance • 2 days ago

Novel Drugs Approved By The FDA In 2025

(RTTNews) - The U.S. Food and Drug Administration (FDA) in 2025 approved 46 novel drugs, including 34 new molecular entities (NMEs) and 12 biologics. The approved drugs treated indications ranging from advanced or refractory breast and lun... Full story

Yahoo Finance • 2 days ago

GSK withdraws autism drug application backed by Trump after recent submission

[Glaxo Smith Kline headquarters, London] William Barton * U.S. regulators have withdrawn their approval of a GSK Plc (GSK [https://seekingalpha.com/symbol/GSK]) drug that the Trump administration had promoted as a treatment for autism.... Full story

Yahoo Finance • 4 days ago

Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks rose late Wednesday afternoon, with the NYSE Health Care Index adding 1.6% and th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 days ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index and the State Street He PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 days ago

GSK gets China approval for Exdensur in nasal polyps, expanding respiratory portfolio

[GSK -Glaxosmithkline headquarters office building in Poznan.] Magdalena Wygralak * GSK plc (GSK [https://seekingalpha.com/symbol/GSK]) Wednesday said that China has approved its drug Exdensur (depemokimab) as an additional treatment fo... Full story

Yahoo Finance • 5 days ago

Australia Drug Delivery Devices Market Trends by Type of Product, Application Area and End-user - Forecast to 2035

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Australia Drug Delivery Devices Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product, Application Area and End-user" has been added to ResearchAndMarke... Full story

Yahoo Finance • 9 days ago

Mental Health Market Set to Surpass USD 668.62 Billion by 2035, Owing to the Increased Adoption of Digital Care and AI-Driven Therapies – SNS Insider

Austin, United States, April 03, 2026 (GLOBE NEWSWIRE) -- As per SNS Insider, The global Mental Health Market was estimated at USD 449.96 billion in 2025 and is projected to hit USD 668.62 billion by 2035, recording a CAGR of 4.04% over... Full story

Yahoo Finance • 10 days ago

No deal yet? Trump readies new tariffs on select drugmakers - report

[Senior woman buying medicine at drugstore] Luis Alvarez The Trump administration plans to impose tariffs on pharmaceutical companies that haven't agreed to lower U.S. drug prices, with an announcement expected as soon as Thursday, _Bloom... Full story

Yahoo Finance • 11 days ago

Renal Cell Carcinoma Market Report 2026-2030 & 2035: Increasing Immunotherapy and Precision Oncology Programs Drives Market Expansion, Reaching USD 6.09 Billion by 2030

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Renal Cell Carcinoma Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides a comprehensive analysis, depicting global market size, regional shares,... Full story

Yahoo Finance • 13 days ago

GSK (GSK) Shares Up Significantly Since Jim Cramer Said to Buy it “and Put it Away”

Pharma giant GSK (NYSE:GSK) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks. Pharma giant GSK (NYSE:GSK) made a move to enter the weight loss market earlier this year after it announced that it would acquire 35Pharma and... Full story

Yahoo Finance • 13 days ago

Cutaneous Squamous Cell Carcinoma (cSCC) Market Rises to $8.33 Billion in 2026: Roche, Merck & Co., and Sanofi Leads the Industry

Company Logo Key opportunities include non-surgical treatments, outpatient procedures, and global expansion, particularly in Asia-Pacific. Major players are focusing on immuno-oncology advancements. Cutaneous Squamous Cell Carcinoma (cSC... Full story

Yahoo Finance • 13 days ago

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

Company Logo The market offers key opportunities through the growth of personalized therapies, adoption of monoclonal antibodies, digital health integration, and innovative solutions like irinotecan liposome injections. Rising incidence a... Full story

Yahoo Finance • 13 days ago

GSK Announces Approval For Exdensur In China

(RTTNews) - GSK plc (GSK, GSK.L) announced that China's National Medical Products Administration has approved Exdensur or depemokimab as add-on maintenance treatment of severe asthma characterised by an eosinophilic phenotype in adult and... Full story

Yahoo Finance • 16 days ago

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

European equities traded in the US as American depositary receipts were little changed late Friday m PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 16 days ago

Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players

Company Logo Opportunities in the anti-cancer mAbs market include growth in personalized cancer medicine, expansion of biosimilar mAbs, and increased oncology spending Anti-Cancer MAbS MarketAnti-Cancer MAbS Market·GlobeNewswire Inc. Du... Full story

Yahoo Finance • 16 days ago

GSK: European Medicines Agency To Review MAA For Bepirovirsen

(RTTNews) - GSK plc (GSK, GSK.L) announced that the European Medicines Agency has accepted for review the marketing authorisation application for the use of bepirovirsen, an investigational antisense oligonucleotide, in the treatment of ad... Full story

Yahoo Finance • 21 days ago

Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Novartis in focus

Wall Street's major averages closed deep in the red on Friday, with oil sustaining higher prices even as Israeli Prime Minister Netanyahu said the country is helping to reopen the Strait of Hormuz. The benchmark S&P 500 ended -1.5%, while... Full story

Yahoo Finance • 22 days ago

Trump administration reportedly shortlisting CDC nominees

[Centers for disease control and prevention sign] sshepard Two physicians with somewhat contrasting views on vaccines are among the potential candidates the Trump administration is considering as its pick to lead the U.S. Centers for Dise... Full story

Yahoo Finance • 26 days ago

Myriad Genetics Gains FDA Nod For Ovarian Cancer Test

(RTTNews) - Myriad Genetics, Inc., (MYGN) announced that the U.S. FDA has approved its MyChoice CDx Test as the companion diagnostic for Zejula, a PARP inhibitor developed by GSK, for patients with advanced ovarian cancer. The approval is... Full story